Streetbeat News

Assets

NXTC

NextCure announced that its current financial resources, including cash, cash equivalents, and marketable securities, are expected to support its operating expenses and capital expenditures until the second half of 2026.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 12:57 pm

NXTC

NextCure reported a reduced annual EPS of $(2.25) for FY23 compared to $(2.69) in FY22. The company's cash reserves decreased to $108.3M from $159.9M, primarily due to operational expenses and asset purchases. Research and development expenses dropped to $47.9M, and general and administrative expenses decreased to $19.7M, contributing to a lower net loss of $62.7M for the year.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 12:56 pm

ALAB

AMD

AMZN

INTC

NVDA

Astera Labs Inc (NASDAQ:ALAB), a provider of semiconductor connectivity solutions, surged 72% in its Nasdaq debut, closing at $62.03 and reaching a market cap of $9.5 billion. The company raised $700 million in its IPO, highlighting strong demand for AI technologies. Astera Labs supplies to major tech companies like Nvidia, AMD, Intel, and Amazon, positioning it as a significant player in the AI infrastructure ecosystem. Amazon's strategic investment in Astera Labs further emphasizes its potential in the AI space.

Portfolio Pulse from Surbhi Jain

March 21, 2024 | 12:56 pm

SPY

Vanguard, a leading U.S. asset manager, expressed skepticism about the Federal Reserve cutting interest rates within the current year, according to a report by CNBC. This stance could influence market expectations and investment strategies.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 12:51 pm

SPY

The Q4 Current Account deficit was reported at $194.8 billion, which is lower than the estimated $209.0 billion. This indicates a better-than-expected performance of the US economy's international transactions.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 12:30 pm

AMTX

Aemetis, Inc. has received approval from the US Citizenship and Immigration Services for $200 million of investments under the EB-5 Program. This program allows foreign investors to invest in US projects that create jobs in exchange for a chance to earn a green card. The approval marks a significant milestone for Aemetis, potentially boosting its project funding capabilities and accelerating its growth initiatives.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 12:06 pm

LOBO

LOBO EV Technologies Ltd. announced its initial public offering (IPO) of 1.38 million shares at $4 per share, aiming to raise $5.5 million. The shares will start trading on Nasdaq under the symbol 'LOBO' on March 21, 2024. Kingswood Capital Partners, LLC is the sole bookrunner for the offering.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 12:02 pm

RHP

Ryman Hospitality Properties announced its subsidiaries, RHP Hotel Properties and RHP Finance Corporation, plan to offer up to $800M in senior notes due 2032 through a private placement.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 12:01 pm

EWU

The Bank of England has decided to keep the Bank Rate steady at 5.25%. This decision could influence market perceptions and potentially impact related financial assets, including ETFs like EWU that track the UK market.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 12:01 pm

PYXS

Pyxis Oncology (NASDAQ:PYXS) reported a FY EPS of $(1.85), surpassing the $(1.95) estimate, marking a 49.32% improvement from last year's $(3.65) per share loss. With $120.8M in cash and an additional $10.8M and $50M expected from an ATM offering and private placement, the company anticipates a cash runway into the second half of 2026.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:41 am